International Graphite (ASX: IG6) strikes European graphite processing JV with Italian chemical group ALKEEMIA at Porto Marghera
Infosys agrees to acquire Optimum Healthcare IT for $465m in its second-largest deal, targeting AI-led transformation of US provider market
The Las Vegas Strip just got a pricing experiment, and MGM Resorts International is betting guests will notice
Read More 2 minute read Pharma Industry News PvP Biologics launches Phase 1 trials for celiac disease candidate Kuma062 PvP Biologics, a US-based pharmaceutical company, has recently begun two phase 1 clinical trials to assess the safety,… bypharmanewsdailySeptember 8, 2018
